El impacto de las condiciones socioeconómicas en la evolución de la enfermedad de Chagas crónica

Revista Espanola de Cardiologia - Tập 62 - Trang 1224-1232 - 2009
Rodolfo Viotti1, Carlos A. Vigliano1, María G. Álvarez1, Bruno E. Lococo1, Marcos A. Petti1, Graciela L. Bertocchi1, Alejandro H. Armenti1
1Servicio de Cardiología y Laboratorio de investigación en Chagas. Hospital Eva Perón. San Martín. Buenos Aires. Argentina

Tài liệu tham khảo

Feldman, 2000, Myocarditis, N Engl J Med, 343, 1388, 10.1056/NEJM200011093431908

Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay, 2006:OPS/HDM/CD/425.

WHO Technical Report Series 905. Control of Chagas disease. Second report of the WHO Expert Committee. Geneva: World Health Organization; 2002.

Marin-Neto, 2007, Pathogenesis of chronic Chagas heart disease, Circulation, 115, 1109, 10.1161/CIRCULATIONAHA.106.624296

Jones, 1993, Amplification of a Trypanosoma cruzi DNA sequence of inflammatory lesions in human chagasic cardiomyopathy, Am J Trop Med Hyg, 48, 348, 10.4269/ajtmh.1993.48.348

Schijman, 2004, Trypanosoma cruzi DNA in cardiac lesions of Argentinean patients with end-stage chronic Chagas heart disease, Am J Trop Med Hyg, 70, 210, 10.4269/ajtmh.2004.70.210

Ouaissi, 2001, Trypanosoma cruzi induced host immune system dysfunction: a rationale for parasite immunosuppressive factor(s) encoding gene targeting, J Biomed Biotechnol, 1, 111, 10.1155/S1110724301000055

Andrade, 1999, Immunopathology of Chagas disease, Mem Inst Oswaldo Cruz, 94, 71, 10.1590/S0074-02761999000700007

Cançado, 1999, Criteria of Chagas disease cure, Mem Inst Oswaldo Cruz, 94, 331, 10.1590/S0074-02761999000700064

Viotti, 1994, Treatment of chronic Chagas’ disease with benznidazole clinical and serologic evolution of patients with long-term follow-up, Am Heart J, 127, 151, 10.1016/0002-8703(94)90521-5

Viotti, 2005, Indicadores clínicos de progresión de la miocarditis chagásica crónica, Rev Esp Cardiol, 58, 1037, 10.1157/13078551

Rassi, 2006, Development and validation of a simple risk score for predicting mortality in Chagas’ heart disease, N Engl J Med, 355, 799, 10.1056/NEJMoa053241

Kaplan, 1993, Socioeconomic factors and cardiovascular disease: a review of the literature, Circulation, 88, 1973, 10.1161/01.CIR.88.4.1973

Boltvinik, 1995, La pobreza en México. I. Metodologías y evolución, Salud Pública Mex, 37, 288

Boltvinik, 1991, La medición de la pobreza en América Latina, Comercio Exterior, 41, 423

Peña, 2000, The effect of poverty, social inequity, and maternal education on infant mortality in Nicaragua, 1988–1993, Am J Public Health, 90, 64, 10.2105/AJPH.90.1.64

Buchbinder, 2008, Mortalidad infantil y desigualdad socioeconómica en la Argentina. Tendencia temporal, Arch Argent Pediatr, 106, 212

Kuschnir, 1985, Valoración de la función cardiaca por angiografía radioisotópica, en pacientes con cardiopatía chagásica crónica, Arq Bras Cardiol, 45, 249

Ranjit, 2006, Socioeconomic differences in progression of carotid intima-media thickness in the Atherosclerosis Risk in Communities study, Arterioscler Thromb Vasc Biol, 26, 411, 10.1161/01.ATV.0000198245.16342.3d

Galobardes, 2007, Measuring socioeconomic position in health research, Br Med Bull, 81-82, 21, 10.1093/bmb/ldm001

Viotti, 2007, Etiological treatment of chronic Chagas disease: neglected evidence by evidence-base medicine, Expert Rev Anti Infect Ther, 5, 717, 10.1586/14787210.5.4.717

Rojas de Arias, 2007, Social, epidemiological, and control determinants of Chagas disease in American Southern Cone - Working group, Mem Inst Oswaldo Cruz, 102, 23, 10.1590/S0074-02762007005000080

Adler, 1999, Socioeconomic status and health: what we know and what we don’t, Ann N Y Acad Sci, 896, 3, 10.1111/j.1749-6632.1999.tb08101.x

Francolino, 2003, New evidence of spontaneous cure in human Chagas disease, Rev Soc Bras Med Trop, 36, 103, 10.1590/S0037-86822003000100014

Viotti, 2006, Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment, Ann Intern Med, 144, 724, 10.7326/0003-4819-144-10-200605160-00006

Cetron, 1993, Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas’ disease patients with symptomatic versus indeterminate infection, Am J Trop Med Hyg, 49, 370, 10.4269/ajtmh.1993.49.370

Sundquist, 2004, Neighborhood socioeconomic environment and incidence of coronary heart disease: A follow-up study of 25,319 women and men in Sweden, Am J Epidemiol, 159, 655, 10.1093/aje/kwh096

Pappas, 1993, The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986, N Engl J Med, 329, 103, 10.1056/NEJM199307083290207

Colominas, 2005, Factores socioeconómicos y enfermedad cardiovascular. A propósito de la confección de guías de prevención, Rev Fed Arg Cardiol, 34, 235

Zicker, 1988, Chagas disease and social security. A case-control study in an urban area, Goias, Brazil, Rev Saúde Públ, S Paulo, 22, 281, 10.1590/S0034-89101988000400004

Galobardes, 2006, Indicators of socioeconomic position (part 1), J Epidemiol Community Health, 60, 7, 10.1136/jech.2004.023531

Subramanian, 2006, Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989–1991, Am J Epidemiol, 164, 823, 10.1093/aje/kwj313

Marques de Araújo, 2000, The ACHEI Program: Chagas’ disease awareness through comprehensive education in the Municipality of Maringá, Northwest Paraná, Brasil, Revista da Sociedade Brasileira de Medicina Tropical, 33, 565

Pinto Dias, 2001, Chagas disease, environment, participation, and the state, Cad Saúde Pública, 17, 165